MX377864B - Composición de antígeno para detectar enfermedad de chagas. - Google Patents
Composición de antígeno para detectar enfermedad de chagas.Info
- Publication number
- MX377864B MX377864B MX2017005650A MX2017005650A MX377864B MX 377864 B MX377864 B MX 377864B MX 2017005650 A MX2017005650 A MX 2017005650A MX 2017005650 A MX2017005650 A MX 2017005650A MX 377864 B MX377864 B MX 377864B
- Authority
- MX
- Mexico
- Prior art keywords
- cruzi
- composition
- polypeptides
- chagas disease
- antigen composition
- Prior art date
Links
- 241000223109 Trypanosoma cruzi Species 0.000 title abstract 7
- 206010001935 American trypanosomiasis Diseases 0.000 title abstract 6
- 208000024699 Chagas disease Diseases 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 6
- 239000012472 biological sample Substances 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 108090000711 cruzipain Proteins 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56905—Protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/005—Trypanosoma antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/26—Infectious diseases, e.g. generalised sepsis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere a una composición de polipéptidos adecuados para detectar anticuerpos contra Trypanosoma cruzi (T. cruzi) en una muestra biológica aislada que consiste de tres polipéptidos 1F8, JL7 y Cruzipain. Es también parte de la invención un método de producción de una composición soluble e inmunorreactiva de los polipéptidos adecuados para detectar los anticuerpos contra T. cruzi, utilizando la composición de los polipéptidos. Además, la invención se refiere a los métodos para detectar anticuerpos específicos para T. cruzi en una muestra aislada, en donde una composición de los polipéptidos de T. cruzi es utilizada así como un kit de reactivos que comprende la composición de los polipéptidos de T. cruzi.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14192004.1A EP3018479A1 (en) | 2014-11-06 | 2014-11-06 | Antigen composition for detecting Chagas disease |
| PCT/EP2015/075691 WO2016071392A1 (en) | 2014-11-06 | 2015-11-04 | Antigen composition for detecting chagas disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017005650A MX2017005650A (es) | 2017-06-29 |
| MX377864B true MX377864B (es) | 2025-03-10 |
Family
ID=51932184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017005650A MX377864B (es) | 2014-11-06 | 2015-11-04 | Composición de antígeno para detectar enfermedad de chagas. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10094828B2 (es) |
| EP (2) | EP3018479A1 (es) |
| JP (1) | JP6763855B2 (es) |
| CN (1) | CN107003309B (es) |
| ES (1) | ES2705429T3 (es) |
| MX (1) | MX377864B (es) |
| WO (1) | WO2016071392A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3018479A1 (en) * | 2014-11-06 | 2016-05-11 | Roche Diagniostics GmbH | Antigen composition for detecting Chagas disease |
| US12188063B2 (en) | 2019-02-08 | 2025-01-07 | Institute Of Science Tokyo | Enzymatic mutant suitable for homogeneous immunoassay method |
| CN111751416A (zh) * | 2020-07-03 | 2020-10-09 | 福建中医药大学 | 一种新型的美洲大蠊多肽快速检测方法 |
| WO2024229330A1 (en) * | 2023-05-03 | 2024-11-07 | Vida Pharmacal Inc. | Modified chimeric antigens ibmp 8.1 and 8.3 for the detection and diagnosis of trypanosoma cruzi |
| CN121049504A (zh) * | 2025-09-03 | 2025-12-02 | 郑州安图生物工程股份有限公司 | 用于克氏锥虫抗体检测的试剂盒 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0976763B1 (en) * | 1998-07-30 | 2003-11-05 | Innogenetics N.V. | Antigens and immunoassays for diagnosing Chagas' disease |
| PE20050942A1 (es) | 2003-12-04 | 2005-11-10 | Louis V Kirchhoff | Polipeptidos recombinantes para diagnosticar la infeccion con el trypanosoma cruzi |
| EP2182979A4 (en) | 2007-07-30 | 2010-09-08 | Univ Georgia | DIAGNOSTIC ASSAY FOR AN INFECTION WITH TRYPANOSOMA CRUZI |
| WO2010142829A1 (es) * | 2009-06-12 | 2010-12-16 | Consejo Superior De Investigaciones Científicas (Csic) | Método de obtención de datos útiles para el diagnóstico diferencial de la enfermedad de chagas, y para evaluar la respuesta al tratamiento |
| EP3018479A1 (en) * | 2014-11-06 | 2016-05-11 | Roche Diagniostics GmbH | Antigen composition for detecting Chagas disease |
-
2014
- 2014-11-06 EP EP14192004.1A patent/EP3018479A1/en not_active Ceased
-
2015
- 2015-11-04 WO PCT/EP2015/075691 patent/WO2016071392A1/en not_active Ceased
- 2015-11-04 MX MX2017005650A patent/MX377864B/es unknown
- 2015-11-04 EP EP15790541.5A patent/EP3215848B1/en active Active
- 2015-11-04 CN CN201580060438.1A patent/CN107003309B/zh active Active
- 2015-11-04 JP JP2017523282A patent/JP6763855B2/ja active Active
- 2015-11-04 ES ES15790541T patent/ES2705429T3/es active Active
-
2017
- 2017-05-05 US US15/587,842 patent/US10094828B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3215848A1 (en) | 2017-09-13 |
| US20170248597A1 (en) | 2017-08-31 |
| MX2017005650A (es) | 2017-06-29 |
| EP3215848B1 (en) | 2018-10-10 |
| CN107003309A (zh) | 2017-08-01 |
| ES2705429T3 (es) | 2019-03-25 |
| US10094828B2 (en) | 2018-10-09 |
| EP3018479A1 (en) | 2016-05-11 |
| CN107003309B (zh) | 2020-05-19 |
| WO2016071392A1 (en) | 2016-05-12 |
| JP2017534055A (ja) | 2017-11-16 |
| JP6763855B2 (ja) | 2020-09-30 |
| BR112017006569A2 (pt) | 2018-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR107078A1 (es) | Anticuerpo antimiostatina, polipéptidos que contienen regiones fc variantes así como métodos de uso | |
| DOP2018000259A (es) | Proteínas de unión biespecíficas que se unen a una proteína inmunomoduladora y a un antígeno tumoral | |
| AR103161A1 (es) | Anticuerpos antimiostatina y regiones fc variantes así como métodos de uso | |
| MX2019008221A (es) | Anticuerpo anti-gpc3. | |
| MX2017013777A (es) | Metodo para el tratamiento de cancer. | |
| MX387936B (es) | Metodo para la cuantificacion de huevos de parasitos en las heces. | |
| MX2017005650A (es) | Composicion de antigeno para detectar enfermedad de chagas. | |
| PE20210107A1 (es) | Anticuerpos anti-cd3 y metodos de uso | |
| AR099465A1 (es) | Anticuerpos anti-jagged1 y métodos de uso | |
| AR090903A1 (es) | Anticuerpos e inmunoconjugados anti-pmel17 | |
| CL2016001867A1 (es) | Sistema y dispositivo para la generación de alto rendimiento de gotitas y métodos de uso combinatorios. | |
| BR112016010822A2 (pt) | anticorpos específicos para fcrn | |
| AR090884A1 (es) | Moleculas de anticuerpo anti-gcc y uso de las mismas para probar la susceptibilidad a la terapia dirigida a gcc | |
| MX2020003523A (es) | Deteccion de dimetilarginina simetrica. | |
| BR112017023131A2 (pt) | anticorpos anti- fcrn | |
| WO2015011282A3 (en) | Method for identifying modulators of bcrp/abcg2-mediated atp release and use of said modulators for treating diseases | |
| BR112016008477A2 (pt) | Corpos, ácido nucleico, célula hospedeira, método de produção de um anticorpo, imunoconjugado, formulação farmacêutica e usos do anticorpo | |
| MX2019002578A (es) | Métodos de detección de la expresión del ligando 1 de muerte programada por célula y usos de los mismos. | |
| BR112017010078A2 (pt) | composições, dispositivos e métodos de teste de sensibilidade de ibs | |
| EP3100046A4 (en) | Detection of prostate specific membrane antigen (psma) expression on circulating tumor cells (ctc) | |
| BR112016009460A8 (pt) | método para detectar a presença de anticorpos neutralizantes, e, kit | |
| IL250867A0 (en) | Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm | |
| NI201600127A (es) | PROTEÍNAS DE FUSIÓN TATk-CDKL5, COMPOSICIONES FORMULACIONES Y USO DE ESTA. | |
| WO2013181576A3 (en) | Methods of evaluating and making biologics | |
| BR112016028838A2 (pt) | anticorpos, ácido nucleico, célula hospedeira, método de produção de um anticorpo, imunoconjugado, formulação farmacêutica, métodos de detecção de lgr5 humano em uma amostra biológica, de detecção de um câncer, de identificação de um paciente com câncer, de seleção de um paciente com câncer para tratamento com um imunoconjugado e de tratamento de um paciente com câncer |